Sort
30,917 grants matching “tumor microenvironment”
Project 3 â Stromal derived IL-6/STAT3 signaling in the development and progression of PDAC
$427,428Michael C Ostrowski · Medical University Of South Carolina · P01 · FY2021 · CA
Project 2:Nanoparticle-based Immune Modulators in Cancer Therapy & Vaccines
$427,406Jenny P.y. Ting · Univ Of North Carolina Chapel Hill · U54 · FY2019 · CA
Rewired Metabolism Regulates Vessel Normalization and Immunosuppression
$427,384Xiang Zhang · Baylor College Of Medicine · R01 · FY2019 · CA
The Role of Collagen and its Signaling Mechanisms in Glioma Progression and Invasion.
$427,257Pedro R Lowenstein · University Of Michigan At Ann Arbor · R01 · FY2025 · NS
Regulation of CD8+T cells by Zbtb42
$427,257Venuprasad K Poojary · Ut Southwestern Medical Center · R01 · FY2023 · CA
Exploiting immunostimulatory microbial pattern recognition to improve head and neck cancer therapy
$427,208Xiang-Yang Wang · Virginia Commonwealth University · R01 · FY2025 · DE
Proteases in Prostate Cancer Bone Metastasis
$427,131Wayne State University · R01 · FY2004 · DK
Microphysiological platform for analyzing multiple myeloma's tumor microenvironment, enabling immunotherapy assessment and drug screening.
$427,095Tania Tali Konry · Northeastern University · R33 · FY2024 · CA
Regulation of the tumor microenvironment by DNA damage repair proteins
$427,084Svasti Haricharan · San Diego State University · R37 · FY2025 · CA
Project 1: Overcoming resistance of B cell leukemia to CD19 CAR T Cells.
$427,021David Porter · University Of Pennsylvania · P01 · FY2019 · CA
Overall
$427,010Gabriele Bergers · University Of California, San Francisco · U54 · FY2014 · CA
Project 4: Using Synthetic Immunology to Improve Activity and Specificity, and Overcome Resistance, in Cellular Therapy
$426,943David A Scheinberg · Sloan-Kettering Inst Can Research · P01 · FY2023 · CA
Project 4: Using Synthetic Immunology to Improve Activity and Specificity, and Overcome Resistance, in Cellular Therapy
$426,943David A Scheinberg · Sloan-Kettering Inst Can Research · P01 · FY2019 · CA
Project 4: Using Synthetic Immunology to Improve Activity and Specificity, and Overcome Resistance, in Cellular Therapy
$426,943David A Scheinberg · Sloan-Kettering Inst Can Research · P01 · FY2020 · CA
Establishment of immunocompetent spontaneous glioma model to study glioma-associated astrocytes
$426,938Tomasz K Kordula · Virginia Commonwealth University · R21 · FY2021 · NS
Metabolism Informs Intertumoral & Intratumoral Heterogeneity
$426,906Jeremy N Rich · Cleveland Clinic Lerner Com-Cwru · R01 · FY2014 · NS
Intraoperative Polarization-Sensitive OCT for Assessing Breast Tumor Margins
$426,904Stephen A Boppart · University Of Illinois At Urbana-Champaign · R01 · FY2019 · CA
A Bioprinted Volumetric Model of Vascularized Glioblastoma
$426,834Y. Shrike Zhang · Brigham And Women'S Hospital · R01 · FY2025 · CA
Microenvironmental Influences in Cancer
$426,752Jin Chen · Vanderbilt University · T32 · FY2019 · CA
Project 3: Analysis of intrinsic and extrinsic factors that promote prostate neuroendocrine differentiation
$426,728Michael M. Shen · Columbia University Health Sciences · P01 · FY2023 · CA
Antimetastatic Drug Discovery that Targets Metabolic Plasticity
$426,720Yu-Dong Zhou · University Of Mississippi · R15 · FY2016 · CA
Gene Expression of Neuroblastoma and Normal Cells in Bone Marrow Predicts Outcome
$426,711Robert C Seeger · Children'S Hospital Of Los Angeles · R33 · FY2012 · CA
Deconstruct tumor microenvironment in medulloblastoma
$426,672Hui Zong · University Of Virginia · R01 · FY2018 · NS
Normalizing Breast Cancer Metabolism to Prevent Progression and Recurrence (PQ21)
$426,659Brunhilde Felding-Habermann · Scripps Research Institute, The · R01 · FY2014 · CA
Impeding HIV-1-associated Non-Hodgkin's Lymphoma development by antagonizing Vpr
$426,604Kyung W Lee · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA